Resideo Technologies (REZI) just closed out FY 2025 with Q4 revenue of US$1.9b and basic EPS of US$0.75, alongside net income of US$113m that capped off a trailing twelve month loss of US$562m and basic EPS of US$3.77 loss. The company has reported quarterly revenue between US$1.77b and US$1.94b over the past year, while EPS moved from a loss of US$5.48 in Q2 2025 to a profit of US$0.88 in Q3 and US$0.75 in Q4, so investors are watching how quickly margins can stabilise from here.
See our full analysis for Resideo Technologies.With the headline numbers on the table, the next step is to see how this earnings print lines up against the most widely held narratives around Resideo, and where the story might need updating.
See what the community is saying about Resideo Technologies
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Resideo Technologies on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
If this mix of risks and potential rewards feels finely balanced, do not wait for others to decide for you. Instead, weigh the data and check the 3 key rewards and 1 important warning sign to shape your own view.
Resideo’s trailing US$562m loss, weak debt coverage and reliance on ambitious margin forecasts all point to meaningful earnings and balance sheet uncertainty.
If you want to reduce that kind of uncertainty in your own portfolio, check out our solid balance sheet and fundamentals stocks screener (40 results) to focus on companies with stronger financial footing today.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com